Low-molecular-weight heparin protects kidney through an anti-apoptotic mechanism in a rat pre-eclamptic model

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 188, Issue , 2015, Pages 51-55

  Zhang, Yuan ^a   Liu, Fengyan ^a   Chen, Sijin ^a   Zhong, Mei ^a  

^a FIRST MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Kidney; Low molecular weight heparin; Pre eclampsia

Indexed keywords

CASPASE 3; CREATININE; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NADROPARIN; PROTEIN; PROTEIN BAX; PROTEIN BCL 2; ANTICOAGULANT AGENT; BAX PROTEIN, RAT; LOW MOLECULAR WEIGHT HEPARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIAPOPTOTIC ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; APOPTOSIS; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DRUG ACTIVITY; DRUG MECHANISM; FEMALE; FETUS; FETUS WEIGHT; HEPARINIZATION; KIDNEY FUNCTION; KIDNEY PARENCHYMA; MALE; NONHUMAN; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL; ANIMAL; BLOOD; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; GENETICS; KIDNEY; LITTER SIZE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PRE-ECLAMPSIA; PREGNANCY; PROTEINURIA; WISTAR RAT;

ANIMALS; ANTICOAGULANTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOOD PRESSURE; BLOOD UREA NITROGEN; CASPASE 3; CREATININE; DISEASE MODELS, ANIMAL; FEMALE; FETAL WEIGHT; HEPARIN, LOW-MOLECULAR-WEIGHT; KIDNEY; LITTER SIZE; NG-NITROARGININE METHYL ESTER; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PROTEINURIA; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 84928809129     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2015.02.001     Document Type: Article

References (25)

1. B.M. Sibai Diagnosis and management of gestational hypertension and preeclampsia Obstet Gynecol 102 2003 181 192
2. P. Lopez-Jaramillo, J.P. Casas, and N. Serrano Preeclampsia: from epidemiological observations to molecular mechanisms Braz J Med Biol Res 34 2001 1227 1235
3. B. Sibai, G. Dekker, and M. Kupferminc Pre-eclampsia Lancet 365 2005 785 799
4. K.S. Khan, D. Wojdyla, and L. Say et al. WHO analysis of causes of maternal death: a systematic review Lancet 367 2006 1066 1074
5. M. de Swiet Maternal mortality: confidential enquiries into maternal deaths in the United Kingdom Am J Obstet Gynecol 182 2000 760 766
6. S. Mantha, K.A. Bauer, and J.I. Zwicker Low molecular weight heparin to achieve live birth following unexplained pregnancy loss: a systematic review J Thromb Haemost 8 2010 263 268
7. E. Gandara, M. Carrier, and M.A. Rodger Intermediate doses of low-molecular-weight heparin for the long-term treatment of pregnancy thromboembolism: a systematic review Thromb Haemost 111 2014 559 561
8. A. Rousseau, R. Favier, and P. Van Dreden Elevated circulating soluble thrombomodulin activity, tissue factor activity and circulating procoagulant phospholipids: new and useful markers for pre-eclampsia? Eur J Obstet Gynecol Reprod Biol 146 2009 46 49
9. X. Yang, L. Guo, and X. Sun et al. Protective effects of hydrogen-rich saline in preeclampsia rat model Placenta 32 2011 681 686
10. J.J. Vanderlelie, and A.V. Perkins Chronic nitric oxide synthase inhibition in pregnant rats does not result in placental oxidative stress Hypertens Pregnancy 25 2006 103 114
11. 4 prevents left ventricular dysfunction in an animal model of preeclampsia Am J Obstet Gynecol 195 2006 1398 1403
12. M. Molnar, T. Suto, T. Toth, and F. Hertelendy Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation Am J Obstet Gynecol 170 1994 1458 1466
13. E. Mooi, and M. Sarstedt Chapter 6, Hypothesis testing & ANOVA A concise guide to market research: the process, data, and methods using IBM SPSS statistics 2011 Springer ISBN: 978-3-642-12540-9 (Print) 978-3-642-12541-6 (Online)
14. P. Lopez-Jaramillo, W.D. Arenas, and R.G. Garcia et al. The role of the l-arginine-nitric oxide pathway in preeclampsia Ther Adv Cardiovasc Dis 2 2008 261 275
15. N.H. Morris, B.M. Eaton, and G. Dekker Nitric oxide, the endothelium, pregnancy and pre-eclampsia Br J Obstet Gynaecol 103 1996 4 15
16. Y.H. Yu, L.Y. Shen, and H. Zou et al. Heparin for patients with growth restricted fetus: a prospective randomized controlled trial J Matern Fetal Neonatal Med 23 2010 980 987
17. V. Conserva, M. Muggiasca, and L. Arrigoni et al. Recurrence and severity of abnormal pregnancy outcome in patients treated by low-molecular-weight heparin: a prospective pilot study J Matern Fetal Neonatal Med 25 2012 1467 1473
18. A.D. Allaire, K.A. Ballenger, and S.R. Wells et al. Placental apoptosis in preeclampsia Obstet Gynecol 96 2000 271 276
19. D.N. Leung, S.C. Smith, and K.F. To et al. Increased placental apoptosis in pregnancies complicated by preeclampsia Am J Obstet Gynecol 184 2001 1249 1250
20. N. Ishihara, H. Matsuo, and H. Murakoshi et al. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation Am J Obstet Gynecol 186 2002 158 166
21. E. DiFederico, O. Genbacev, and S.J. Fisher Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall Am J Pathol 155 1999 293 301
22. A.E. Heazell, H.R. Buttle, P.N. Baker, and I.P. Crocker Altered expression of regulators of caspase activity within trophoblast of normal pregnancies and pregnancies complicated by preeclampsia Reprod Sci 15 2008 1034 1043
23. A. Kukner, F. Tore, and T. Firat et al. The preventive effect of low molecular weight heparin on CCL(4)-induced necrosis and apoptosis in rat liver Ann Hepatol 9 2010 445 454
24. L.N. Hao, Q.Z. Zhang, and T.G. Yu et al. Antagonistic effects of ultra-low-molecular-weight heparin on Abeta25-35-induced apoptosis in cultured rat cortical neurons Brain Res 1368 2011 1 10
25. T.G. Yu, Q.Z. Zhang, and Z.G. Zhang et al. Protective effect of ultra low molecular weight heparin on glutamate-induced apoptosis in cortical cells Yonsei Med J 49 2008 486 495